<DOC>
	<DOCNO>NCT01576575</DOCNO>
	<brief_summary>The purpose study determine people absorb break ( metabolize ) eliminate buprenorphine CYP3A involve .</brief_summary>
	<brief_title>Buprenorphine Disposition Clinical Effects</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Each subject must meet following criterion : 1 . Male nonpregnant female volunteer , 1850 yr old 2 . Good general health know major medical condition 3 . BMI 2033 4 . Provide informed consent Subjects enrol follow criterion exist : 1 . Known history liver kidney disease 2 . Use prescription nonprescription medication , herbal food know metabolized affect CYP3A activity ( include use oral contraceptive ) . 3 . Females pregnant nursing 4 . Known history drug alcohol addiction ( prior present addiction addiction treatment ) 5 . Direct physical access routine handle addict drug regular course duty ( routine exclusion study drug addiction potential )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>determine people absorb break ( metabolize ) eliminate buprenorphine CYP3A involve .</keyword>
</DOC>